AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
NEWS & MEDIA
ALLFEATURED
AI supports targeted therapy recommendations fortumor diseases – BMBF funds
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
OncoCoin AG donates for a charity bicycle tour: Tour of
Bad Hersfeld / Germany, Aug 02, 2022– Mayor Thomas Fehling took the opportunity at the Smart City Forum, which took…
Innoplexus and Innovatrix capital partner to bring about new risk-transfer
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…
Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform
COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBORN, Germany, Boston,…
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and ESCHBORN, Germany,…
Wie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz…
Der Pharma-Visionär
Mit künstlicher Intelligenz gegen Krankheiten: Wie Gunjan Bhardwaj die Regeln der Arzneimittelforschung umschreiben will – für schnellere Ergebnisse und bessere…
Künstliche Intelligenz unterstützt Suche nach Wirkstoff gegen Corona
Hessen fördert Forschungsprojekt mit rund 1,4 Mio. Euro. Mit einem Zuschuss von 1,4 Mio. Euro unterstützt Hessen die Entwicklung eines Wirkstoffkandidaten…
New app for cancer patients
Das Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen…
Role of AI soars in tackling Covid-19 pandemic
For the first time in a pandemic, Artificial Intelligence (AI) is playing a role like never before in areas ranging…
Innoplexus Announces Major Findings in Potential Combination Therapies for COVID-19
Disclaimer: This press release and our findings are solely intended as information for the scientific community. This content is not intended…
Catana Capital: New collaboration with Life Science AI pioneer Innoplexus
Catana Capital partners with a leading provider of AI solutions in the Life Science sector Frankfurt am Main, December 16, 2019: As…
Innoplexus and Wiley partner to provide AI-powered solutions over comprehensive
Frankfurt, Germany, October 15, 2019 – Innoplexus AG announces a partnership with John Wiley & Sons, Inc. (NYSE: JW-A) (NYSE:…
Innoplexus and ChemAxon partner to get more out of life
Frankfurt, Germany – Budapest, Hungary, September 16, 2019 – Innoplexus announces an official partnership with ChemAxon, getting the most value…
Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer
Hoboken, New Jersey, September 16, 2019- Innoplexus Inc., a subsidiary of Innoplexus AG, announced today the appointment of Stratos Davlos…
Innoplexus Announces Appointment of Rita Kelley as Senior Vice President
Hoboken, New Jersey, September 12, 2019 – Innoplexus Inc, a subsidiary of Innoplexus AG, Frankfurt, which has developed the most…
Innoplexus and Cures Within Reach for Cancer Tap the Power
Hoboken, NJ, August 5, 2019 – Innoplexus Holdings, Inc., a leader in artificial intelligence (AI) solutions for the life sciences…
Innoplexus Launches Worldwide Academic Access Program for its Flagship Ontosight.ai
Frankfurt, Germany, May 21, 2019 — Innoplexus announced today the launch of Ontosight Academic, a platform that provides academic researchers…
INNOPLEXUS WIEDER IM GARTNER HYPE CYCLE FÜR LIFE SCIENCES
Eschborn, Januar 2019. Das weltweit angesehene US-Analystenhaus Gartner Inc. veröffentlicht jährlich seinen Hype Cycle für Life Sciences, um Unternehmensvorstände zu…
Innoplexus’ Clinical Trial Prediction Engine predicted Aducanumab Failure
Frankfurt, Germany – On March 21st, 2019, Biogen’s stock declined sharply, showing a decrease of 29%, resulting in losses to…
